Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon in chronic active hepatitis B. Preliminary results.

I Waked1, M Amin, S A Abd-el Fattah

  • 1Department of Medicine and Clinical Pathology, Ain-Shams University, Cairo, Egypt.

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|June 1, 1988
PubMed
Summary

Alpha-2b interferon therapy for chronic active hepatitis B led to significant HBeAg clearance. Most treated patients lost the e antigen and developed antibodies, indicating viral suppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TGF-β1 Directs TFAM-Mediated Mitochondrial Reprogramming in Oral Submucous Fibrosis.

Journal of dental research·2025
Same author

Enhancing sustainability in soldering: effects of recycled welding slag and rice husk ash on microstructural, thermal, and mechanical properties of Sn-Cu composite solders.

Scientific reports·2025
Same author

Recommendations for Integrating Caries Risk Assessment into Primary Care for Indigenous Children.

JDR clinical and translational research·2025
Same author

Central vein sign and paramagnetic rim lesion abbreviated counting methods for diagnosis of multiple sclerosis: a systematic review and meta-analysis.

Clinical radiology·2025
Same author

A micellar nanoprobe for fluorescence image-guided delineation of glioblastoma margins.

Pharmacological research·2025
Same author

Vegetation-edaphic correlation and importance value index in himalayan 'ecotone' temperate conifer forest using the multivariate technique.

Saudi journal of biological sciences·2024

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic active hepatitis B is a significant global health concern.
  • Hepatitis B e antigen (HBeAg) positivity indicates active viral replication.
  • Effective antiviral therapies are crucial for managing chronic hepatitis B.

Purpose of the Study:

  • To evaluate the efficacy of alpha-2b interferon in treating chronic active hepatitis B.
  • To assess the impact of interferon on HBeAg seroconversion and antibody development.

Main Methods:

  • Twenty patients with chronic active hepatitis B were randomized into two groups.
  • The treatment group received subcutaneous alpha-2b interferon (5 IU thrice weekly for 16 weeks).
  • The control group received no treatment.

Related Experiment Videos

Main Results:

  • All 10 patients in the interferon group lost HBeAg, compared to only 2 in the control group.
  • Six treated patients developed HBe antibodies versus two in the control group.
  • Ongoing follow-up will assess long-term viral replication markers.

Conclusions:

  • Alpha-2b interferon shows promise in achieving HBeAg clearance in chronic active hepatitis B.
  • Interferon therapy may induce immune responses against the hepatitis B virus.
  • Further studies are needed to confirm long-term benefits and optimal treatment strategies.